Mackenzie Financial’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-9,555
Closed -$290K 1713
2025
Q3
$290K Buy
9,555
+2,275
+31% +$69K ﹤0.01% 1423
2025
Q2
$228K Hold
7,280
﹤0.01% 1500
2025
Q1
$278K Buy
7,280
+1,920
+36% +$81.5K ﹤0.01% 1402
2024
Q4
$235K Sell
5,360
-450
-8% -$19.8K ﹤0.01% 1491
2024
Q3
$250K Sell
5,810
-960
-14% -$42.8K ﹤0.01% 1274
2024
Q2
$306K Sell
6,770
-1,330
-16% -$69K ﹤0.01% 1159
2024
Q1
$506K Hold
8,100
﹤0.01% 1022
2023
Q4
$454K Hold
8,100
﹤0.01% 1024
2023
Q3
$407K Hold
8,100
﹤0.01% 1052
2023
Q2
$512K Hold
8,100
﹤0.01% 1012
2023
Q1
$433K Sell
8,100
-512
-6% -$29.7K ﹤0.01% 1064
2022
Q4
$461K Buy
+8,612
New +$444K ﹤0.01% 953

Other funds holding ENOV

Mackenzie Financial's ENOV Position: Q4 2025 in Review

Mackenzie Financial sold out of Enovis (ENOV) in Q4 2025, closing a stake of 9,555 shares — an estimated $290K sold.

Mackenzie Financial first reported a position in ENOV in Q4 2022 and held it in 12 quarters. The position peaked at $512K in Q2 2023. 254 funds tracked by Wall St. Rank hold ENOV as of Q4 2025.

  • Mackenzie Financial reported no remaining Enovis position as of Q4 2025 after selling out during the quarter.
  • Mackenzie Financial sold 9,555 Enovis shares in Q4 2025, an estimated $290K.
  • Mackenzie Financial first reported a position in Enovis in Q4 2022 and held it in 12 quarters.
  • Mackenzie Financial's Enovis position peaked at $512K in Q2 2023.
  • 254 funds tracked by Wall St. Rank held Enovis as of Q4 2025.

Based on Mackenzie Financial's 13F filing for Q4 2025, filed 18 Feb 2026.